VIGL Vigil Neuroscience Inc.: Nilai bisnis marang pendapatan

Vigil Neuroscience (VIGL) relies on partnerships with scientific foundations to accelerate the development of dementia drugs. The business valuation relative to revenue reflects market expectations, where the mark indicates the current valuation level. Price growth depends on the results of phase two trials, although the lack of profit and dependence on external investments create significant risks.
Vigil Neuroscience Inc. - rincian analitis lan metrik utama (VIGL)

Investors utilize this ratio for comparative asset analysis, as it benchmarks Enterprise Value against annual revenue, neutralizing the impact of debt on the valuation. The stability of this metric is supported by the security of Vigil Neuroscience (VIGL) operational supply chains for raw materials, which minimizes production risks and is reflected in the EV/Sales ratio trend.